Skip to content

Depression research published in 2013

Page 2 of 2: studies 21 to 22 of 22, newest first. Back to the depression overview

Studies

Ketamine for the Treatment of Depression

Journal of Psychosocial Nursing and Mental Health Services 2013 Robert H Howland

Ketamine (Ketalar®) is an anesthetic agent derived from the hallucinogenic drug phencyclidine (PCP). It is a high-affinity antagonist at N-methyl-D-aspartate receptors and also binds to opioid mu and sigma receptors. Ketamine is being intensively investigated as an antidepressant therapy. To date, five short-term controlled studies and other open-label studies in patients with unipolar or...

Meditative movement for depression and anxiety.

Frontiers in Psychiatry 2013 Peter Payne, Mardi A Crane-Godreau

This review focuses on Meditative Movement (MM) and its effects on anxiety, depression, and other affective states. MM is a term identifying forms of exercise that use movement in conjunction with meditative attention to body sensations, including proprioception, interoception, and kinesthesis. MM includes the traditional Chinese methods of Qigong (Chi Kung) and Taijiquan (Tai Chi), some forms...